Professional societies issue position statement on transcatheter valve therapy

Published date : 30 June 2011
Article date : 30 June 2011

The American College of Cardiology Foundation (AACF) and the Society for Thoracic Surgeons (STS) have published a combined statement on the implementation of transcatheter heart valve replacement. They recommend a combination of good practice measures including team working, data collection in trial settings, nominated centres and good training. This is to be applauded, and reflects concerns about the potentially transformational nature of this kind of intervention, offering therapy for patients who may be considered too unwell for traditional open approaches.

The Edwards Sapien heart valve is one such device. It went on sale in Europe in 2010, and a decision from the FDA in July 2011 is expected to be positive.
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.